Neural Copper Homeostasis: the role of the Alzheimer Amyloid-beta Precursor Protein

阿尔茨海默病(AD)正在给澳大利亚的医疗资源带来越来越大的负担。铜在阿尔茨海默病的发展中起着重要作用，旨在调整大脑铜水平的药物正在测试中，用于治疗阿尔茨海默病，并显示出治疗效果。该项目将确定铜是如何参与AD的，以便开发更有效的药物。重点将主要放在AD中心的铜结合蛋白，包括淀粉样β蛋白，以及它们在AD发展中的作用。在这个项目完成后，我们希望更好地了解健康和AD病理中的神经铜代谢，结果直接适用于治疗性AD干预。

Alzheimer's disease (AD) is creating a growing burden upon Australian medical resources. Copper plays an important role in the development of AD, and drugs designed to adjust brain copper levels are being tested for AD treatment and show therapeutic benefits. This project will determine how copper is involved in AD so that more effective drugs can be developed. Focus will primarily be on copper-binding proteins central to AD, including amyloid-beta, and their role in AD development. Upon completion of this project, we expect to better understand neural copper metabolism in health and in AD pathology, with outcomes directly applicable to therapeutic AD intervention.